Durvalumab vs Rosuvastatin

## Durvalumab vs Rosuvastatin: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Rosuvastatin**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Rosuvastatin**: Competitive inhibitor of HMG-CoA reductase.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Rosuvastatin — 19 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Rosuvastatin — C22H28FN3O6S.

**Molecular Weight**: Durvalumab — N/A; Rosuvastatin — 481.5390 g/mol.

**Type**: Durvalumab — Antibody; Rosuvastatin — Small molecule.